The Role of Chitinase 3-Like-1 (YKL-40) and Proinflammatory Biomarkers in the Pathogenesis of Pediatric Tick-Borne Encephalitis in a Polish Cohort
Ewa Bojkiewicz,Kacper Toczylowski,Dawid Lewandowski,Diana Martonik,Robert Flisiak,Artur Sulik
DOI: https://doi.org/10.2147/jir.s480556
IF: 4.5
2024-12-06
Journal of Inflammation Research
Abstract:Ewa Bojkiewicz, 1 Kacper Toczylowski, 1 Dawid Lewandowski, 1 Diana Martonik, 2 Robert Flisiak, 2 Artur Sulik 1 1 Department of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland; 2 Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland Correspondence: Kacper Toczylowski, Email Background: Chitinase 3-like-1 (CHI3L1), also known as YKL-40, is a potential biomarker for neuroinflammatory conditions. It is upregulated in Alzheimer's disease, multiple sclerosis, and traumatic brain injury. However, its involvement in pediatric tick-borne encephalitis (TBE) has not been addressed yet. This study aimed to evaluate CHI3L1 and its relationship with other inflammatory cytokines, blood-brain barrier (BBB) integrity, immune response, and disease severity in pediatric patients with TBE. Patients and Methods: A total of 22 pediatric TBE patients hospitalized in Bialystok, Poland were included in this study. Participants were categorized as having meningoencephalitis (n=6) or meningitis (n=16). The integrity of the brain-blood barrier (BBB) was assessed using the albumin quotient (albQ). Biomarker indices were calculated to account for variations in BBB permeability. The concentrations of CHI3L1, CCL2, chemerin, CXCL2, IFN-γ, IL-1-β, IL-4, IL-6, IL-13, and TNF-α in both serum and CSF, were measured using the Luminex Multiplex Assay od admission and two weeks later when symptoms resolved. Results: CSF and serum concentrations of CHI3L1 did not differ between the encephalitis and meningitis cases. After adjusting for BBB permeability, the CHI3L1 index was 2.4-fold lower in patients with encephalitis than in those with meningitis (P=0.008). There was a post-treatment reduction of CHI3L1, IL-6, and TNF-α CSF concentrations. We also found and improvement in BBB permeability in younger children but in older albQ remained abnormal. Correlation analysis revealed associations between CHI3L1 levels and pro-inflammatory markers, notably chemerin, IL-6, and TNF-α, across both clinical groups. Conclusion: Our findings suggest that CHI3L1 CSF levels reflect the inflammatory activity in pediatric TBE and may help to differentiate between meningoencephalitis and meningitis. The observed interactions between CHI3L1 and other cytokines underscore its potential involvement in inflammatory response to the virus. The prolonged disruption in BBB integrity in older children might reflect age-dependent differences in the severity of TBE. These insights advance our understanding of TBE pathogenesis in children and support further investigation of CHI3L1 as a biomarker for TBE diagnosis and management. Keywords: chitinase-3-like-1, tick-borne encephalitis, blood-brain barrier, ticks, chemokines Tick-borne encephalitis (TBE) is one of the most prevalent viral infections of the central nervous system (CNS) in Poland and is caused by the tick-borne encephalitis virus (TBEV). 1 This virus predominantly spreads through infected ticks of the genus Ixodes and can culminate in severe sequelae. The mortality rate for TBE vary depending on the virus subtype. Case-fatality rate is estimated to be less than 2% for European and Siberian subtype, while infections with Far Eastern TBEV subtype have a mortality rate of 20%-40%. 2 Reports indicate that 20–58% of patients suffer from complications such as spinal nerve paresis, hearing impairment, dysarthria, or mental disorders. 2,3 The recovery time for TBE can varies depending on the severity of the infection. In general, it may take several weeks to 12 months for a complete recovery, especially in cases with neurological involvement. While it has been proven that the severity of complications continue to diminish beyond a year after the acute illness, some individuals experience post - encephalitic syndrome (PES) that can become permanent, with some individuals not achieving full recovery even 15 years after infection. 4 TBEV infections have been on the rise across Europe, with Poland experiencing an annual caseload ranging from 150 to 283, predominantly concentrated in the northeastern region. 5 Diagnosing TBE relies on clinical symptoms and the detection of specific antibodies in both serum and cerebrospinal fluid (CSF), which are present in general in 93% of patients. 6 While CSF characteristics can vary depending on the disease stage and the patient there are some characteristic findings. Reports show that approximately 70–90% of patients may have elevated albumin concentrations. Higher albumin CSF/serum quotient, along with elevated IgG index, are observed in a similar proportion of cases, roughly i -Abstract Truncated-
immunology